BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26817783)

  • 1. Preadmission use of renin-angiotensin blockers and rupture of abdominal aortic aneurysm: a nationwide, population-based study.
    Wemmelund H; Høgh A; Hundborg HH; Johnsen SP; Lindholt JS
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):141-50. PubMed ID: 26817783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal Aortic Aneurysms Pharmacoepidemiological Studies.
    Wemmelund H
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and rupture of abdominal aortic aneurysm.
    Wemmelund H; Høgh A; Hundborg HH; Thomsen RW; Johnsen SP; Lindholt JS
    Br J Surg; 2014 Jul; 101(8):966-75. PubMed ID: 24849021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose aspirin and rupture of abdominal aortic aneurysm.
    Wemmelund H; Jørgensen TM; Høgh A; Behr-Rasmussen C; Johnsen SP; Lindholt JS
    J Vasc Surg; 2017 Mar; 65(3):616-625.e4. PubMed ID: 27460909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study.
    Christiansen CF; Heide-Jørgensen U; Rasmussen TB; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Pottegård A; Lund LC; Reilev M; Hallas J; Johansen NB; Brun NC; Sørensen HT; Thomsen RW
    J Am Heart Assoc; 2020 Oct; 9(19):e017297. PubMed ID: 32998607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair.
    Salata K; Syed M; Hussain MA; Eikelboom R; de Mestral C; Verma S; Al-Omran M
    J Vasc Surg; 2018 Feb; 67(2):629-636.e2. PubMed ID: 29175038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study.
    Kristensen KE; Torp-Pedersen C; Gislason GH; Egfjord M; Rasmussen HB; Hansen PR
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):733-40. PubMed ID: 25633315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study.
    Slagelse C; Gammelager H; Iversen LH; Liu KD; Sørensen HTT; Christiansen CF
    BMJ Open; 2019 Nov; 9(11):e032964. PubMed ID: 31753901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preadmission use of ACE inhibitors or angiotensin receptor blockers and short-term mortality after stroke.
    Sundbøll J; Schmidt M; Horváth-Puhó E; Christiansen CF; Pedersen L; Bøtker HE; Sørensen HT
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):748-54. PubMed ID: 25209418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
    Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
    Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis.
    Christiansen CF; Pottegård A; Heide-Jørgensen U; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Lund LC; Reilev M; Hallas J; Voldstedlund M; Husby A; Thomsen MK; Johansen NB; Brun NC; Thomsen RW; Bøtker HE; Sørensen HT
    Thorax; 2021 Apr; 76(4):370-379. PubMed ID: 33293279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.
    Butt DA; Mamdani M; Gomes T; Lix L; Lu H; Tu K;
    J Bone Miner Res; 2014 Nov; 29(11):2483-8. PubMed ID: 24806397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term renin-angiotensin blocking therapy in hypertensive patients with normal aorta may attenuate the formation of abdominal aortic aneurysms.
    Silverberg D; Younis A; Savion N; Harari G; Yakubovitch D; Sheick Yousif B; Halak M; Grossman E; Schneiderman J
    J Am Soc Hypertens; 2014 Aug; 8(8):571-7. PubMed ID: 24913570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
    Bandak G; Sang Y; Gasparini A; Chang AR; Ballew SH; Evans M; Arnlov J; Lund LH; Inker LA; Coresh J; Carrero JJ; Grams ME
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms.
    Kristensen KL; Pottegård A; Hallas J; Rasmussen LM; Lindholt JS
    J Vasc Surg; 2017 Sep; 66(3):768-774.e2. PubMed ID: 28506478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.
    Hackam DG; Thiruchelvam D; Redelmeier DA
    Lancet; 2006 Aug; 368(9536):659-65. PubMed ID: 16920471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Is Not Associated with the Risk of Rupture Among Patients with Abdominal Aortic Aneurysms - Results From a Large Danish Register Based Matched Case Control Study From 1996 to 2016.
    Kristensen KL; Rasmussen LM; Hallas J; Lindholt JS
    Eur J Vasc Endovasc Surg; 2020 Jul; 60(1):36-42. PubMed ID: 32253164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
    Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
    J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis: A Population-Based Cohort Study.
    Hsu WT; Galm BP; Schrank G; Hsu TC; Lee SH; Park JY; Lee CC
    Hypertension; 2020 Feb; 75(2):483-491. PubMed ID: 31838905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.